|
Weak biofilm producer (n = 81, 32.7%)
|
30.6
|
17.4
|
43.9
|
66.7
|
13.9
|
77.7
|
|
Modertae biofilm producer (n = 115, 46.3%)
|
42.9
|
56.5
|
50.0
|
22.2
|
47.2
|
73.9
|
|
Strong biofilm producer (n = 52, 20.9%)
|
26.5
|
26.1
|
6.1
|
11.1
|
38.9
|
48.1
|
|
Total (n, %)
|
(98, 39.5%)
|
(23, 9.3%)
|
(82, 33.1%)
|
(9, 3.6%)
|
(36, 14.5%)
|
173
|
|
SarA gene (173, 69.7%)
|
80.6
|
65.2
|
80.5
|
77.7
|
16.6
| |
|
Adhesion Genes
|
|
icaD/ icaA(n = 248)
|
87.7
|
87.0
|
78.0
|
88.9
|
80.6
|
58.5
|
|
Eno (n = 235, 94.8%)
|
92.9
|
91.3
|
97.6
|
100.0
|
94.4
|
71.5
|
|
ClfA (n = 199, 80.2%)
|
92.9
|
87.0
|
89.0
|
55.6
|
27.8
|
80.4
|
|
ClfB (n = 199, 80.2%)
|
92.9
|
87.0
|
89.0
|
55.6
|
27.8
|
80.4
|
|
FnbA (n = 194, 78.2%)
|
87.8
|
78.3
|
91.5
|
66.7
|
25.0
|
81.4
|
|
EbpS (n = 191, 76.2%)
|
82.7
|
60.9
|
84.1
|
55.6
|
55.6
|
76.4
|
|
Fib (n = 154, 62.2%)
|
60.2
|
73.9
|
80.5
|
66.7
|
16.7
|
83.1
|
|
Cna (n = 99, 39.9%)
|
46.9
|
21.7
|
53.7
|
0.0
|
11.1
|
78.8
|
|
FnbB (n = 72, 29.0%)
|
52.0
|
21.7
|
13.4
|
11.1
|
11.1
|
81.9
|
|
Antibiotic Resistance
|
|
Cefoxitin/Penicillin (n = 248)
|
100.0
|
100.0
|
100.0
|
100.0
|
100.0
|
100
|
|
Erythromycin (n = 163)
|
59.2
|
60.9
|
69.5
|
33.3
|
86.1
|
63.2
|
|
Ciprofloxacin (n = 109)
|
58.2
|
56.5
|
20.7
|
33.3
|
52.8
|
63.3
|
|
Clindamycin (n = 95)
|
28.6
|
43.5
|
48.8
|
11.1
|
44.4
|
65.3
|
|
Gentamycin (n = 58)
|
27.6
|
21.7
|
11.0
|
22.2
|
41.7
|
55.2
|
|
SXT (n = 55)
|
19.4
|
21.7
|
11.0
|
11.1
|
58.3
|
41.8
|
|
MDR (n = 66)
|
22.4
|
43.5
|
13.4
|
11.1
|
61.1
|
46.9
|
|
Source of isolate
|
|
Wound (n = 78)
|
36.7
|
34.8
|
35.4
|
22.2
|
8.3
|
80.7
|
|
Blood (n = 34)
|
11.2
|
17.4
|
11.0
|
11.1
|
25.0
|
52.9
|
|
Nasal (n = 25)
|
11.2
|
13.0
|
8.5
|
0.0
|
11.1
|
64
|
|
Pus (n = 23)
|
8.2
|
8.7
|
13.4
|
22.2
|
0.0
|
95.6
|
|
Urine (n = 23)
|
1.0
|
0.0
|
11.0
|
22.2
|
30.6
|
43.5
|
|
Tissue (n = 13)
|
9.2
|
8.7
|
2.4
|
0.0
|
0.0
|
61.5
|
|
Sputum (n = 12)
|
3.1
|
8.7
|
6.1
|
0.0
|
5.6
|
58.3
|
|
Other sites (n = 40)
|
19.4
|
8.7
|
12.2
|
22.2
|
19.4
|
72.5
|
